Intranasal Insulin for the Treatment of Persistent Post-COVID-19 Olfactory Dysfunction.

Giancarlo B CherobinRoberto E S GuimarãesMárcia C de Paula GomesLuís O G VasconcelosLígia A N de Abreu

Published in: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (2023)

Our results suggest that the administration of NPH insulin into the olfactory cleft yields a rapid improvement in the sense of smell of patients suffering from persistent post-COVID-19 olfactory dysfunction. Moreover, the procedure seems to be safe and tolerable.

Keyphrases

coronavirus disease
sars cov
type diabetes
end stage renal disease
ejection fraction
newly diagnosed
oxidative stress
glycemic control
minimally invasive
prognostic factors
respiratory syndrome coronavirus
peritoneal dialysis
insulin resistance
metabolic syndrome
sensitive detection